Skip to main content
PLOS One logoLink to PLOS One
. 2025 Dec 5;20(12):e0336589. doi: 10.1371/journal.pone.0336589

Knowledge, attitude and practices among Healthcare Workers towards Pulmonary Plague Infection following an outbreak in Madagascar, 2017: A pilot study

Inessa Markus 1,2,#, Lynn Meurs 1,2,#, Rebekah Wood 3, Vaoary Razafimbia 4, Andrianasolo Radonirina 5, Delphin Kolie 6, Rapelerano Rabenja Fahafahantsoa 5, Alexandre Delamou 7, Jan Walter 1, Matthias Borchert 3,, Thomas Paerisch 8,‡,*
Editor: Beza Ramasindrazana9
PMCID: PMC12680261  PMID: 41348822

Abstract

Objectives

To assess training needs of healthcare workers (HCWs) on pulmonary plague (PP) control after the large PP outbreak in Madagascar 2017.

Methods

In 2018, we conducted a knowledge, attitudes and practices (KAP) survey among HCWs (PP cases and comparison group) in Antananarivo and Toamasina. Proportions were calculated, differences between groups were tested for significance.

Results

Knowledge levels were similar for HCW PP cases and the HCW comparison group. Among 59 HCW over 90% named the distinctive disease forms of plague (bubonic (93%), pulmonary (98%)), and 72% the causative agent. Washing hands was mentioned as protective measure by 56%, while 93% reported to have always washed hands after performing medical procedures. Only 3.5% reported managed PP cases before the outbreak; 38% reported to have felt confident performing invasive procedures while caring for PP cases at the beginning versus 62% at the end of the outbreak. HCW who remained uninfected reported more often than PP cases to have worn multiple or single use medical coats ((93% vs. 53%, p = 0.001; 60% vs. 20%, p = 0.028), and less frequently to have paid for chemoprophylaxis out of pocket (11% versus 50%; p = 0.008).

Conclusion

Despite the good overall knowledge, specific knowledge gaps and the mismatch between knowledge and practice of basic hygiene measures and low confidence in providing care for PP cases after the outbreak indicate a persisting need for training.

Introduction

Plague is considered endemic only in a few regions of the world. Single cases or small outbreaks were reported in the United States of America and in Kyrgyzstan, but the most affected countries according to WHO are the Democratic Republic of Congo, Peru and Madagascar. Over 75% of plague cases worldwide occur in Madagascar [1]. Until 2017, plague cases in Madagascar occurred mostly in rural regions, with a seasonal increase from October to April. Between 1998 and 2016, 88% of the cases reported were classified as bubonic plague (BP) [2]. Despite effective antibiotic treatment being available, prevention and control of the disease remain challenging, leading to its endemic persistence [35]. The large outbreak in 2017 was unusual in that it occurred between July and November, produced a large proportion of pulmonary plague (PP) cases, and affected urban areas like Antananarivo and Toamasina. 1878 of the 2412 notified cases (78%) in this time period were classified as PP [6], including 81 HCWs who were diagnosed with and treated for PP according to WHO [7]. Due to potential close contact with infected patients, healthcare workers (HCWs) are at high risk during outbreaks of PP, but only limited literature exists on transmission patterns and risk factors for infection among HCWs, and on their knowledge of the disease and treatment procedures [810]. Given the relatively high number of PP cases among HCWs reported during the 2017 Malagasy outbreak (N = 81), we aimed at investigating possible knowledge gaps, unhelpful attitudes and unsafe practices during the outbreak that may have facilitated transmission to HCWs in order to better understand possible causes for infection and develop locally relevant infection prevention and control (IPC) training to be better prepared for future plague outbreaks.

KAP surveys are used to assess knowledge, attitude and practices (KAP) of a selected population regarding a specific topic. They are commonly used in the health sector to gather before-and-after data on public health interventions [1113]. For emerging diseases in limited resource settings, KAP surveys can help to develop targeted interventions addressing the most relevant problems and improve response measures in case of an outbreak. For example, during the Ebola Virus Disease outbreak in West Africa, KAP surveys contributed to describing and understanding the persisting perceptions and beliefs around the disease in the community [1416].

There is only limited literature on experiences of HCW on treatment of pulmonary plague in hospital settings [8, 17]. Therefore, we conducted the study to gather more information to support the development of context-adapted strategies for diagnosis, treatment and prevention of nosocomial transmission, with sufficient resources, including trained HCWs available on different levels of care.

Materials and methods

Study design

In September 2018, we conducted a cross-sectional survey in four hospitals in the Malagasy capital Antananarivo, and in two hospitals and one mobile team in the Malagasy city Toamasina, which were the most affected urban areas during the outbreak. The KAP survey was conducted in HCWs from the hospital departments where PP cases had arisen among HCWs that were involved in PP treatment, and from mobile teams that were involved in community outreach and body management of patients who died due to PP in the 2017 outbreak.

From 81 HCW plague cases reported by WHO [7], 29 PP cases were selected from the Ministry of Health’s national Directorate of Health and Epidemiological Surveillance (DVSSE) database, based on geographical location (Antananarivo and Toamasina) and work in a health care facility at the time of study in 2018. These were contacted and invited to participate in the study (Fig 1).

Fig 1. Sampling scheme.

Fig 1

Sampling scheme of DVSSE – Ministry of Health’s national Directorate of Health and Epidemiological Surveillance.

Additional HCWs were recruited as a comparison group from the same departments of hospitals where the participating HCW PP cases worked at the time of the study. Eligible comparison HCWs were defined as medical doctors (including medical interns and students), nursing staff (nurses, midwives, and paramedics), and support staff assumed to have been exposed directly or indirectly to PP patients (cleaners, patient transport staff, morgue staff, guards or mobile community outreach staff). Administrative staff, for whom no patient contact was assumed, were excluded. To avoid selection bias, comparison HCWs were systematically sampled from HCW staff lists of each eligible department. The sample size of N = 44 was determined on feasibility grounds, resulting in a sampling fraction of 33% (Fig 1). If a HCW was selected but absent for a long period of time, for example for holidays, another HCW was randomly sampled from the list.

Upon written informed consent, local interviewers administered a structured questionnaire in French or Malagasy in a designated room to ensure privacy. The participants completed the interview in the language of their choice. Study participants received a token of appreciation for their participation (10 000 Ariary phone credit, equivalent to approx. € 2.50).

Data collection

The same questionnaire was used on all participants. It consisted of four sections: (1) demographic data (age, sex, work place, profession, and years of working experience), (2) knowledge (causative agent, transmission, infection prevention and control, symptoms, treatment), (3) attitudes towards PP (level of confidence in treatment and protection measures and material). The 4th section consisted of questions on practices during the epidemic (use of existing guidelines, availability of chemoprophylaxis, protection material and treatment). High-risk procedures were defined as suction, intubation, sputum sampling and cleaning of surfaces. Examples for invasive procedures, such as drawing blood and delivery, and examples for non-invasive procedures, such as performing ultrasound or ECG, were provided in the questionnaire. A sheet with photographs of the personal protection equipment was used to assess which items were used. At the end of the interview all HCWs were invited to demonstrate how to wear a surgical mask, which was assessed by a member of the research team.

Data analysis and definitions

Throughout the epidemic, different case definitions for plague were applied. The DVSSE database we used for recruiting HCW PP cases consisted of cases based on clinical, epidemiological and laboratory criteria.

After double data entry and validation, we used STATA 15 (StataCorp LLC, College Station, Texas, USA) for data management and analysis. A descriptive analysis was performed using ranges, frequency counts (n) and proportions (%).

We looked at differences in self-reported practice during the outbreak between HCW PP cases from the DVSSE database irrespective of the classification as suspected, probable or confirmed case with the comparison group. Due to the changes in the case definition and its unclear effect on the classification of cases in the database, as well as anecdotal evidence of problems with transport of samples and on-site testing with rapid diagnostic tests, we conducted the same comparison on the subset of PCR-confirmed cases versus the corresponding subset of HCWs who worked in the same departments as the PCR positive cases. None of the cases had a positive culture and only one case had a positive serology result recorded in the database.

The threshold for a group having “good knowledge” was defined as ≥75%, while the threshold for a group “lacking knowledge” was defined as <40%.

For better readability, we limit the reporting of digits to two meaningful digits, as in 45%, 4.5% or 0.45%. As a result of this rounding policy, percentages may add up to slightly less or more than 100%. For the comparison of proportions, Fisher’s exact test was performed. We applied a significance level of p < 0.05, and did not correct for multiple testing since we conducted an explorative study and did not test for any predefined hypothesis.

Ethics statement

Human participants were included. Written informed consent was obtained from study participants. Ethics clearance was obtained from the Committee of Ethics in Biomedical Research of the Ministry of Health in Madagascar on 30 April 2018 (File No. 048-MSANP/CERBM). A permission to conduct the study within the public health care setting was obtained by the national Ministry of Health of Madagascar. Data protection clearance was granted at Robert Koch Institute, Germany.

Results

Characteristics of the study population

From the 29 eligible HCW PP cases from the national DVSSE case database 15 HCW could be traced back and agreed to participate (Fig 1). These HCW were working in seven different institutions in Antananarivo (four hospitals) and Toamasina (two hospitals, one mobile team), where an additional 44 HCWs were recruited as a comparison group, resulting in a total of 59 participants. The remaining 14 HCW PP cases had changed positions or hospitals after the outbreak, were on leave during the study, or refused to participate and could therefore not be included in the study.

From the 59 HCW, 54% were working in Antananarivo and 46% in Toamasina at the time of the survey. More female (63%) than male HCW (37%) were in the sample with an age range of 22–59 years. Most participants were medical doctors including medical interns and students (41%) or nursing staff (41%). Eleven HCWs (19%) were support staff (cleaners, patient transport staff, morgue staff, guards or mobile community outreach staff). The majority of HCWs (78%) reported to have more than five years of working experience, and most confirmed to have received a salary (92%); four volunteers reported to not have received any financial compensation during the outbreak (Table 1).

Table 1. Demographic characteristics of participating health care workers (HCWs).

All HCWs (N = 59) HCW pulmonary plague (PP) cases (N = 15) HCW comparison group (N = 44)
City
Antananarivo 32 (54%) 5 (33%) 27 (61%)
Toamasina 27 (46%) 10 (67%) 17 (39%)
Gender
male 22 (37%) 7 (47%) 15 (34%)
female 37 (63%) 8 (53%) 29 (66%)
Age range (years) 22 - 59 22 - 58 24 - 59
Profession
Medical Doctors* 24 (41%) 7 (47%) 17 (39%)
Nursing staff** 24 (41%) 6 (40%) 18 (41%)
Support staff*** 11 (19%) 2 (13%) 9 (21%)
Working experience (years)
< 2 years 6 (10%) 2 (13%) 4 (9.1%)
2-5 years 10 (17%) 2 (13%) 8 (18%)
>5 years 43 (78%) 11 (73%) 32 (73%)
Received salary during the outbreak 54 (92%) 12 (80%) 42 (96%)

* including medical interns and students

** Nurses, midwives, and paramedics

*** Cleaners, patient transport staff, morgue staff, guards and mobile community outreach staff

From the 15 HWCs recorded as PP cases, 6 HCWs had a positive PCR confirming the infection according to the DVSSE database. Five HCWs were from Antananarivo and 10 HCW from Toamasina. The distribution of professional groups among HCW PP cases and the HCW of the comparison group was similar. The age among the 15 HCW PP cases ranged from 22 to 58 years and among the comparison group from 24 to 59 years (Table 1).

Knowledge on pulmonary plague

Almost all participants were aware that PP was a contagious disease (98%) to which no immunity is developed (83%, Table 2).

Table 2. General knowledge among health care workers (HCWs) concerning the disease, prevention and treatment.

All HCWs (N=59)* HCW pulmonary plague (PP) cases (N=15) HCW comparison group (N=44)
To which extent do you agree with the following statement: “Pulmonary plague is a contagious disease” **p=1.0
Some agreement 1 (1.7%) 0 (0%) 1 (2.3%)
Total agreement 58 (98%) 15 (100%) 43 (98%)
To which extent do you agree with the following statement: “Certain people are immune towards PP” p=0.10
Does not know 3 (5.1%) 2 (13%) 1 (2.3%)
Does not agree 49 (83%) 11 (73%) 38 (86%)
Some agreement 1 (1.7%) 1 (6.7%) 0 (0%)
Total agreement 6 (10%) 1 (6.7%) 5 (11%)
What is the pathogen of PP? p=0.65
N=58 N=15 N=43
Does not know 4 (6.9%) 0 (0%) 4 (9.3%)
Virus 11 (19%) 4 (27%) 7 (16%)
Parasite 1 (1.7%) 0 (0%) 1 (2.3)
Bacteria 42 (72%) 11 (73%) 31 (72%)
What are different clinical forms of plague? (Please mention the types you know)
Bubonic **p=1.0 55 (93%) 14 (93%) 41 (93%)
Pulmonary p=1.0 58 (98%) 15 (100%) 43 (98%)
Primary or secondary pulmonary p=1.0 4 (6.8%) 1 (6.7%) 3 (6.8%)
Septicemic p=0.48 12 (20%) 4 (27%) 8 (18%)
What are the (main) symptoms of PP? (Please mention the one you know)
Fever p=0.16 56 (95%) 13 (87%) 43 (98%)
Dyspnea p=0.76 23 (39%) 5 (33%) 18 (41%)
Coughing p=1.0 47 (80%) 12 (80%) 35 (80%)
Chest pain p=0.11 20 (34%) 8 (53%) 12 (27%)
Expectorations p=0.48 46 (78%) 13 (87%) 33 (75%)
Speaking of prevention methods against PP in hospitals, can you tell me which ones you know?
Isolation p=0.17 44 (75%) 9 (60%) 35 (80%)
Washing hands p=0.23 33 (56%) 6 (40%) 27 (61%)
Chemoprophylaxis p=0.55 39 (66%) 11 (73%) 28 (64%)
Patients wearing a surgical mask p=0.75 40 (68%) 11 (73%) 29 (66%)
HCWs wearing a mask p=0.27 55 (93%) 13 (87%) 42 (95%)
Wearing gloves p=0.48 47 (80%) 11 (73%) 36 (82%)
Can you name a drug to take in case of chemoprophylaxis?
Co-trimoxazole p=0.70 49 (83%) 12 (80%) 37 (84%)
Doxycycline p=0.22 39 (66%) 12 (80%) 27 (61%)
Ciprofloxacin p=1.0 18 (31%) 4 (27%) 14 (32%)

*N = 59 unless stated otherwise; N < 59 because of missing data.

**P-values derived from Fisher’s exact test. p < 0.05 in bold; 0.10 > p ≥ 0.05 in bold italics

Most participants knew that the plague is caused by bacteria (72%), but some thought that it is caused by a virus (19%). Few HCWs mentioned the septicemic form of plague (20%) and certain symptoms of PP (chest pain 34%, dyspnea 39%). Most frequently mentioned protective measures were HCWs wearing a mask (93%) and using gloves (80%). Most HCWs knew the following preventive measures: isolating patients (75%), asking patients to wear a mask (68%), taking chemoprophylaxis (66%), and washing hands (56%). When asked about chemoprophylaxis, a majority of HCWs specified co-trimoxazole (83%), followed by doxycycline (66%) and ciprofloxacin (31%). With respect to PP knowledge there were no significant differences between the HCW PP cases and the HCW comparison group.

Attitudes

The reported confidence in terms of treating patients increased over the course of the outbreak: the proportion of HCWs who reported to have felt totally confident treating PP cases including invasive procedures rose from 38% at the beginning of the outbreak to 62% at its end (Table 3).

Table 3. Attitudes towards pulmonary plague (PP) among health care workers (HCWs).

All HCWs (N=59)* HCW PP cases (N=15) HCW comparison group (N=44)
Indicate the extent to which you agree with the following statements:
“I was confident in performing the high-risk procedures at the beginning of the 2017 epidemic” **p=0.46
N=50 N=12 N=38
Total agreement 19 (38%) 5 (42%) 14 (37%)
Some agreement 7 (14%) 0 (0%) 7 (18%)
No agreement 23 (46%) 7 (58%) 16 (42%)
I don’t know 1 (2.0%) 0 (0%) 1 (2.6%)
“I was confident in performing the high-risk procedures towards the end of the 2017 epidemic” p=0.41
N=50 N=12 N=38
Total agreement 31 (62%) 6 (50%) 25 (66%)
Some agreement 9 (18%) 2 (17%) 7 (18%)
No agreement 10 (20%) 4 (33%) 6 (16%)
How would you describe your knowledge of preventing nosocomial/hospital PP transmission? p=0.50
N=58 N=15 N=43
Expert knowledge 6 (10%) 1 (6.7%) 5 (12%)
Intermediate knowledge 32 (55%) 9 (60%) 23 (53%)
Basic knowledge 15 (26%) 3 (20%) 12 (28%)
No knowledge 3 (5.2%) 2 (13%) 1 (2.3%)
I don’t know 2 (3.5%) 0 (0%) 2 (4.7%)
How easy is it to protect yourself from transmission of PP in a hospital setting? p=0.067
Very easy 0 (0%) 0 (0%) 0 (0%)
Easy 27 (46%) 3 (20%) 24 (55%)
Average 11 (19%) 3 (20%) 8 (18%)
Difficult 14 (24%) 6 (40%) 8 (18%)
Very difficult 7 (12%) 3 (20%) 4 (9.1%)
How easy is it to treat patients with pneumonic plague in a hospital setting? p=0.29
Very easy 4 (6.8%) 3 (20%) 1 (2.3%)
Easy 29 (49%) 6 (40%) 23 (52%)
Average 6 (10%) 1 (6.7%) 5 (11%)
Difficult 17 (29%) 5 (33%) 12 (27%)
Very difficult 1 (1.7%) 0 (0%) 1 (2.3%)
I don’t know 2 (3.4%) 0 (0%) 2 (4.6%)
Indicate the extent to which you agree with the following statement:
“I trust the personal protective equipment.” p=0.13
N=58 N=14 N=44
Total agreement 33 (57%) 8 (57%) 25 (57%)
Some agreement 17 (29%) 2 (14%) 15 (34%)
No agreement 8 (14%) 4 (29%) 4 (9.1%)
“I trust the drugs for chemoprophylaxis.” p=0.041
Total agreement 39 (66%) 7 (47%) 32 (73%)
Some agreement 18 (31%) 6 (40%) 12 (27%)
No agreement 2 (3.4%) 2 (13%) 0 (0%)
“I was afraid of getting infected with PP at work (in the hospital) during the epidemic.” p=0.57
Total agreement 40 (68%) 10 (67%) 30 (68%)
Some agreement 4 (6.8%) 0 (0%) 4 (9.1%)
No agreement 14 (24%) 5 (33%) 9 (20%)
I don’t know 1 (1.7%) 0 (0%) 1 (2.3%)
“I was afraid of contracting pneumonic plague outside work during the epidemic.” p=0.44
Total agreement 39 (66%) 9 (60%) 30 (68%)
Some agreement 3 (5.1%) 0 (0%) 3 (6.8%)
No agreement 17 (29%) 6 (40%) 11 (25%)
“During the epidemic the workload was too high.” p=0.85
N=57 N=15 N=42
Total agreement 45 (79%) 13 (87%) 32 (76%)
Some agreement 4 (7.0%) 1 (6.7%) 3 (7.1%)
No agreement 8 (14%) 1 (6.7%) 7 (17%)
“During the epidemic we were understaffed.” p=0.088
N=57 N=15 N=42
Total agreement 36 (63%) 13 (87%) 23 (55%)
Some agreement 3 (5.3%) 0 (0%) 3 (7.1%)
No agreement 18 (32%) 2 (13%) 16 (38%)
Are health workers (in general) sufficiently informed about the transmission of PP? p=0.051
Yes 42 (71%) 8 (53%) 34 (77%)
No 14 (24%) 7 (47%) 7 (16%)
I don’t know 3 (5.1%) 0 (0%) 3 (6.8%)

*N=59 unless stated otherwise; N<59 because of missing data.

**P-values derived from Fisher’s exact test. p < 0.05 in bold; 0.10 > p ≥ 0.05 in bold italics

A small majority of participants (55%) described their level of knowledge of how to prevent nosocomial transmission of PP as intermediate, and only 10% felt to have expert knowledge at the time of the study. A majority felt that HCW in general were sufficiently informed about the transmission routes of PP (71%). Additionally, 46% considered it to be easy to protect themselves in a hospital setting, and 56% considered it to be easy or very easy to treat PP patients. Only 57% of participants trusted protective equipment fully, while 66% fully trusted chemoprophylaxis. About two thirds reported to have feared contracting PP at work (68%) or outside work (66%). A majority of respondents reported a high workload (79%), and felt that the departments were understaffed during the outbreak (63%). HCW PP cases trusted chemoprophylaxis significantly less than the HCW comparison group (47% vs. 73%, p = 0.041). Fewer HCW PP cases than comparison HCWs found it easy to protect themselves from PP transmission in a hospital (20% vs. 55%) and thought HCWs in general to be sufficiently informed about the transmission of PP (53% vs. 77%), while more HCW PP case than comparison HCWs felt that they were understaffed during the epidemic (87% vs. 55%), but these difference failed to gain statistical significance (0.10 > p ≥ 0.05).

Practices

The most common clinical practices were clinical examinations (42%), invasive procedures (39%) and local disinfection (39%). Among high-risk procedures the most common were surface cleaning in treatment centers (37%), followed by sputum sampling (32%) and intubation (25%, Table 4).

Table 4. Self-reported practices of health care workers (HCWs) during the plague epidemic in 2017 (ctd.).

All HCWs HCW PP cases HCW comparison group
Clinical practice N = 59 N = 15 N = 44
“What were you main activities in the hospital during the epidemic”?
Clinical examination p = 0.77
Yes 25 (42%) 7 (47%) 18 (41%)
No 34 (58%) 8 (53%) 26 (59%)
Non-invasive care (e.g., ultrasound, ECG) p = 1.0
Yes 8 (14%) 2 (13%) 6 (14%)
No 51 (86%) 13 (87%) 38 (86%)
Invasive care (e.g., blood sampling, delivery) p = 0.55
Yes 23 (39%) 7 (47%) 16 (36%)
No 36 (61%) 8 (53%) 28 (64%)
Local disinfection p = 1.0
Yes 23 (39%) 6 (40%) 17 (39%)
No 36 (61%) 9 (60%) 27 (61%)
Transport of sick patients p = 1.0
Yes 10 (17%) 2 (13%) 8 (18%)
No 49 (83%) 13 (87%) 36 (82%)
Dead body management p = 0.68
Yes 9 (15%) 3 (20%) 6 (14%)
No 50 (85%) 12 (80%) 38 (86%)
“Which high-risk procedures did you execute?”
Suction p = 1.0
Yes 1 (1.7%) 0 (0%) 1 (2.3%)
No 58 (98%) 15 (100%) 43 (98%)
Intubation p = 0.31
Yes 15 (25%) 2 (13%) 13 (30%)
No 44 (75%) 13 (87%) 31 (70%)
Sputum sampling p = 0.34
Yes 19 (32%) 3 (20%) 16 (36%)
No 40 (68%) 12 (80%) 28 (64%)
Cleaning of surfaces in a treatment center p = 1.0
Yes 22 (37%) 6 (40%) 16 (36%)
No 37 (62%) 9 (60%) 28 (63%)
Experience in care for PP cases prior to the outbreak, and participation in PP training
N = 58 N = 15 N = 43
Did you ever manage cases of PP before the 2017 outbreak? p = 1.0
Yes 2 (3.5%) 0 (0%) 2 (4.6%)
No 55 (95%) 15 (100%) 40 (93%)
I don’t know 1 (1.7%) 0 (0%) 1 (2.3%)
Did you participate in PP courses/trainings before the outbreak? p = 0.16
Yes 12 (21%) 1 (6.7%) 11 (26%)
No 46 (79%) 14 (93%) 32 (74%)
Did you participate in PP courses/trainings during the outbreak? p = 1.0
Yes 29 (50%) 8 (53%) 21 (49%)
No 27 (47%) 7 (47%) 20 (47%)
I don’t know 2 (3.5%) 0 (0%) 2 (4.7%)
Did you participate in PP courses/trainings after the outbreak? p = 0.31
Yes 12 (21%) 5 (33%) 7 (16%)
No 44 (76%) 10 (67%) 34 (79%)
I don’t know 2 (3.5%) 0 (0%) 2 (4.7%)
Did you participate in PP courses/trainings at any point in time? p = 1.0
N = 57 N = 15 N = 42
Yes 42 (74%) 11 (73%) 31 (74%)
No 15 (26%) 4 (27%) 11 (26%)
Demonstration of use of a surgical masque p = 0.37
N = 58 N = 15 N = 43
Correct 28 (48%) 9 (60%) 19 (44%)
Wrong 30 (52%) 6 (40%) 24 (56%)

*N = 59 unless stated otherwise; N < 59 because of missing data.

**P-values derived from Fisher’s exact test. p < 0.05 in bold; 0.10 > p ≥ 0.05 in bold italics

Most HCWs (95%) reported to have followed guidelines during the outbreak. A small majority (54%) of respondents stated that the patients always wore surgical masks during medical care. In regards to their own practice, 46% of the participants responded that they always wore a surgical mask, and 46% to have always worn an FFP2 mask while caring for patients. A large majority of the participants reported to have always worn gloves (86%) and to have always used a multiple use coat (80%). Most HCWs (93%) reported to have always washed their hands after high-risk procedures. Patients with PP were almost always isolated according to participants (97%). The use of chemoprophylaxis during the epidemic was common among the participants (91%). The most common antibiotic used was co-trimoxazole (59%). A minority of participants who reported taking chemoprophylaxis paid out of pocket for it (20%). Almost a quarter of the participants paid themselves for protective material (23%). 49% of the HCWs reported to have taken care of a PP case that they knew personally.

Only 2 HCWs (3.5%) had previous experience in working with PP cases before the 2017 epidemic. A minority of the HCWs reported to have had PP classes or training before the epidemic in 2017 (21%). During the epidemic 50% received training. After the epidemic, 21% attended training on health care provision for PP patients. In total, 26% of HCW had not received any PP training. Only about half of the participants (48%) could correctly demonstrate the use of a surgical mask.

A significantly lower proportion of the cases compared to the comparison group reported to always have worn the multiple use medical coats (53% vs. 93%, p = 0.001) or a single use medical coat (20% vs. 60%; p = 0.028). A significantly higher proportion of the cases reported to have paid for chemoprophylaxis out of their own pockets (50% vs. 11%; p = 0.008). Fewer HCW PP cases than comparison HCWs reported to have followed guidelines or protocols for managing PP patients or preventing PP transmission (87% vs. 98%), but this difference was not significant (0.10 > p ≥ 0.05). Other practices did not differ between HCW PP cases and the HCW comparison group.

We conducted a subgroup analysis of six PCR confirmed cases and their corresponding comparison group of 26 HCWs. We found a significant difference for reported usage of multiple use medical coats (50% versus 100%; p = 0.004; data not shown). A significantly higher proportion of PCR confirmed cases than comparison HCW received training after the outbreak (67% versus 20%; p = 0.043).

Discussion

This study provides information on knowledge, attitudes and practices during the plague outbreak in 2017 and highlights the gaps in IPC training and implementation of IPC measures among HCW in urban areas in Madagascar. We found basic PP knowledge to be overall good. Prevention measures like wearing masks and gloves and isolating patients were well known (≥75% of participants). Some theoretical knowledge, however, was lacking, such as: knowing about the pulmonary and bubonic but not the septicemic form of plague, knowing the unspecific symptom “fever” but not common symptoms “dyspnea” or “chest pain” (<40% of participants). HCWs felt confident about their abilities to treat patients and perceived a learning effect by working during the outbreak. Nonetheless, the results indicate room for improvement, and there remain training needs concerning disease characteristics, necessary IPC measures and their purpose, and the correct use of personal protective equipment.

There were several discrepancies between knowledge and reported practice. First of all, transmission prevention measures like hand washing after providing care for a PP case were mentioned by only half of the HCWs, but when asked about hand hygiene directly, virtually all reported to have practiced it during the epidemic after performing a high-risk procedure. This gap between knowledge and reported practice suggests that HCWs’ reported practices may be overstated compared to actions performed in reality. Alternatively, they may have practiced hand hygiene more often than naming it as preventive measure, suggesting that it may not have been fully understood why certain procedures are important while caring for PP cases. Conversely, a higher proportion of HCWs knew that suspected cases should wear a mask (68%), but a lower proportion reported that this was always done in practice (54%). Also, wearing a mask by HCWs themselves was mentioned by 93% as a protective measure, while only half of them reported to have always worn a surgical or FFP2 mask (46% and 46%, respectively) while caring for patients. In addition, only 48% could demonstrate how to correctly wear a surgical mask. This gap between knowledge and practice in relation to patients may indicate a lack of implementation of, or compliance with, guidelines despite better knowledge, or insufficient availability of protective equipment such as masks. The gap may also be due to the fact that only few HCWs had training before or after the epidemic on handling PP patients. Further training, availability of biosafety guidelines and access to sufficient PPE are likely to increase staff safety and confidence [1820].

A fifth of the HCW participants report to have paid for chemoprophylaxis themselves. This is worrying, since chemoprophylaxis should be provided to exposed HCWs for free. Whether chemoprophylaxis was unavailable to these HCWs, or whether their initiative reflected their fears, could not be distinguished by our study. However, the difference between HCW PP cases and HCW comparison group was particularly striking in this respect: an almost five times higher proportion of cases reported out-of-pocket payment for chemoprophylaxis than HCWs from the comparison group. This may suggest that cases have experienced access barriers to chemoprophylaxis and were, therefore, less well protected against infection. We therefore recommend ensuring equal access to chemoprophylaxis for all exposed HCWs.

The high-risk of contracting PP from working in the hospital or mobile team in the community was perceived as similar to contracting PP from outside the work context. The analysis of 2414 plague cases, 78% PP cases and 16% BP cases, between August and November 2017 did not reveal any recorded nosocomial transmission [6]. Our study population seemed to have overall good knowledge of various aspects of the disease, including its clinical manifestations, and of adequate infection prevention practices. While only a small proportion of the HCWs had received training during and after the epidemic, and a considerable proportion had not received any training at all, the hands-on experience may have led to reported practice being better than theoretical knowledge, and to confidence to treat patients with PP to grow in the course of the epidemic. Worryingly, only half of the HCW (48%) could demonstrate the correct use of a surgical mask, which suggests a persisting need for hands-on training.

The case definition changed over the evolution of the outbreak, which may have contributed to misclassification if HCW were not trained accordingly. Lack of knowledge of case definitions, possibly in combination with lack of knowledge and training on PP, may have contributed to possible misclassification of HCW as PP cases. A sensitive case definition ensured the capture of all suspected cases of PP, which is desirable due to the fast evolution and severity of disease. However, with limited capacity for adequate testing despite having samples from the majority of cases, only 2% of the clinically suspected PP cases in 2017 could be laboratory confirmed [6]. Consequently, the number of PP cases may have been overestimated.

This study has various limitations. We interviewed the HCWs in their working environment, and although we ensured privacy for the interview of each HCW to minimize courtesy bias, they may have been reluctant to voice criticism or report mismanagement for fear of retributions. Our study was carried out one year after the outbreak, and we used photographic prompts to minimize recall bias. Still, our study cannot distinguish with confidence between knowledge and attitudes acquired during vs. after the outbreak, and residual courtesy and recall bias may have embellished the answers on practices during the outbreak. Changes of case definition and availability and reliability of diagnostic tests over the course of the epidemic may have influenced the inclusion of PP cases in the DVSSE database. We could only include those HCW PP cases that remained in the same unit after the outbreak and were available at the time of the study; these may not be fully representative of all HCW PP cases.

Conclusions

This study shows that one year after the 2017 plague epidemic, HCWs in urban areas in Madagascar had an overall good level of knowledge, but only half reported to feel confident treating PP cases despite the hands-on experience during the outbreak. Our results indicate that there may be a persistent need among HCWs for training in IPC methods, such as hand hygiene, PPE use, and adequate isolation, to protect both HCW and patients. Despite awareness of existing guidelines, standard operating procedures for PP-specific PPE-use and management of PP cases tailored to the Malagasy setting may contribute to being better prepared for future large-scale outbreaks.

Supporting information

S1 File. Questionnaire “Inclusivity in global research”.

(DOCX)

pone.0336589.s001.docx (66.2KB, docx)

Acknowledgments

We would like to thank the health care workers who dedicated, despite their heavy workload, significant time to the study team and to make this survey possible. Furthermore, we would like to extend our gratitude to the DVSSE, LARTIC and Pasteur Institute for their invaluable contribution to this study.

Data Availability

Interested researchers can request the de-identified, anonymized dataset underlying the results presented in this study from raharina4@hotmail.com.

Funding Statement

Research for this publication was funded through the Global Health Protection Programme (GHPP) by the Federal Ministry of Health, Germany.

References

  • 1.Rollinson D, Knopp S, Levitz S, Stothard JR, Tchuem Tchuenté L-A, Garba A, et al. Time to set the agenda for schistosomiasis elimination. Acta Trop. 2013;128(2):423–40. doi: 10.1016/j.actatropica.2012.04.013 [DOI] [PubMed] [Google Scholar]
  • 2.Andrianaivoarimanana V, Piola P, Wagner DM, Rakotomanana F, Maheriniaina V, Andrianalimanana S, et al. Trends of Human Plague, Madagascar, 1998-2016. Emerg Infect Dis. 2019;25(2):220–8. doi: 10.3201/eid2502.171974 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Rabaan AA, Al-Ahmed SH, Alsuliman SA, Aldrazi FA, Alfouzan WA, Haque S. The rise of pneumonic plague in Madagascar: current plague outbreak breaks usual seasonal mould. J Med Microbiol. 2019;68(3):292–302. doi: 10.1099/jmm.0.000915 [DOI] [PubMed] [Google Scholar]
  • 4.Riehm JM, Löscher T. Human plague and pneumonic plague : pathogenicity, epidemiology, clinical presentations and therapy. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015;58(7):721–9. doi: 10.1007/s00103-015-2167-9 [DOI] [PubMed] [Google Scholar]
  • 5.Stenseth NC, Atshabar BB, Begon M, Belmain SR, Bertherat E, Carniel E, et al. Plague: past, present, and future. PLoS Med. 2008;5(1):e3. doi: 10.1371/journal.pmed.0050003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Randremanana R, Andrianaivoarimanana V, Nikolay B, Ramasindrazana B, Paireau J, Ten Bosch QA, et al. Epidemiological characteristics of an urban plague epidemic in Madagascar, August-November, 2017: an outbreak report. Lancet Infect Dis. 2019;19(5):537–45. doi: 10.1016/S1473-3099(18)30730-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.World Health Organization. Plague Outbreak Madagascar. 2017. http://apps.who.int/iris/bitstream/handle/10665/259556/Ex-PlagueMadagascar04122017.pdf?sequence=1 [Google Scholar]
  • 8.Kool JL. Risk of person-to-person transmission of pneumonic plague. Clin Infect Dis. 2005;40(8):1166–72. doi: 10.1086/428617 [DOI] [PubMed] [Google Scholar]
  • 9.Mitchell FK. The plague in Cape Town in 1901 and its subsequent establishment as an endemic disease in South Africa. SAMJ. 1983;64:17–9. [PubMed] [Google Scholar]
  • 10.Evans C. Pneumonic plague: incidence, transmissibility and future risks. Hygiene. 2022;2(1):14–27. [Google Scholar]
  • 11.Katler Q, Godiwala P, Macri C, Pineles B, Simon G, Chang A, et al. Evolution of Knowledge, Awareness, and Practices regarding Zika Virus from 2016 to 2017. Infect Dis Obstet Gynecol. 2017;2017:6350602. doi: 10.1155/2017/6350602 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Otu A, Ebenso B, Okuzu O, Osifo-Dawodu E. Using a mHealth tutorial application to change knowledge and attitude of frontline health workers to Ebola virus disease in Nigeria: a before-and-after study. Hum Resour Health. 2016;14:5. doi: 10.1186/s12960-016-0100-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lin Y, Huang L, Nie S, Liu Z, Yu H, Yan W, et al. Knowledge, attitudes and practices (KAP) related to the pandemic (H1N1) 2009 among Chinese general population: a telephone survey. BMC Infect Dis. 2011;11:128. doi: 10.1186/1471-2334-11-128 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Iliyasu G, Ogoina D, Otu AA, Dayyab FM, Ebenso B, Otokpa D, et al. A Multi-Site Knowledge Attitude and Practice Survey of Ebola Virus Disease in Nigeria. PLoS One. 2015;10(8):e0135955. doi: 10.1371/journal.pone.0135955 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Jalloh MF, Bunnell R, Robinson S, Jalloh MB, Barry AM, Corker J, et al. Assessments of Ebola knowledge, attitudes and practices in Forécariah, Guinea and Kambia, Sierra Leone, July-August 2015. Philos Trans R Soc Lond B Biol Sci. 2017;372(1721):20160304. doi: 10.1098/rstb.2016.0304 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ngatu NR, Kayembe NJ-M, Phillips EK, Okech-Ojony J, Patou-Musumari M, Gaspard-Kibukusa M, et al. Epidemiology of ebolavirus disease (EVD) and occupational EVD in health care workers in Sub-Saharan Africa: Need for strengthened public health preparedness. J Epidemiol. 2017;27(10):455–61. doi: 10.1016/j.je.2016.09.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Salam AP, Raberahona M, Andriantsalama P, Read L, Andrianarintsiferantsoa F, Razafinambinintsoa T, et al. Factors Influencing Atypical Clinical Presentations during the 2017 Madagascar Pneumonic Plague Outbreak: A Prospective Cohort Study. Am J Trop Med Hyg. 2020;102(6):1309–15. doi: 10.4269/ajtmh.19-0576 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Allegranzi B, Kilpatrick C, Storr J, Kelley E, Park BJ, Donaldson L, et al. Global infection prevention and control priorities 2018-22: a call for action. Lancet Glob Health. 2017;5(12):e1178–80. doi: 10.1016/S2214-109X(17)30427-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.World Health Organization. Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level. WHO. 2016. https://apps.who.int/iris/handle/10665/251730 [PubMed] [Google Scholar]
  • 20.World Health Organization. Interim practical manual: supporting national implementation of the WHO guidelines on core components of infection prevention and control programmes. WHO; 2017. p. 77. Available from: https://apps.who.int/iris/handle/10665/330073 Access Date: 16.05.2024. [Google Scholar]

Decision Letter 0

Beza Ramasindrazana

9 Apr 2025

-->PONE-D-25-02320-->-->Knowledge, Attitude and Practices among Healthcare Workers towards Pulmonary Plague Infection following an Outbreak in Madagascar, 2017-->-->PLOS ONE

Dear Dr. Paerisch,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 24 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Beza Ramasindrazana

Academic Editor

PLOS ONE

Journal Requirements:

-->1. When submitting your revision, we need you to address these additional requirements.-->--> -->-->Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at -->-->https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and -->-->https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf-->--> -->-->2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met. Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.-->--> -->-->3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. -->--> -->-->When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.-->--> -->-->4. Thank you for stating the following financial disclosure: -->-->Research for this publication was funded through the Global Health Protection Programme (GHPP) by the Federal Ministry of Health, Germany-->-->  -->-->Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." -->-->If this statement is not correct you must amend it as needed. -->-->Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.-->--> -->-->5. In the online submission form, you indicated that The data underlying the results presented in the study are available from the corresponding author.-->--> -->-->All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either a. In a public repository, b. Within the manuscript itself, or c. Uploaded as supplementary information.-->-->This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval.-->--> -->-->6. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.-->

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: No

Reviewer #2: Yes

**********

-->2. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: No

Reviewer #2: Yes

**********

-->3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: No

Reviewer #2: Yes

**********

-->4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: No

**********

-->5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1:  Knowledge, Attitude and Practices among Healthcare Workers towards Pulmonary

Plague Infection following an Outbreak in Madagascar, 2017

The study aimed to assess training needs of healthcare workers (HCWs) on pulmonary plague (PP) control after the Madagascar 2017 large PP outbreak. The authors in 2018, conducted a knowledge, attitudes and practices (KAP) survey among HCWs (PP cases and comparison group) in Antananarivo and Toamasina.

General comments: The study is described as comparative between PP cases and the comparison group, but the rationale for the sample size selection needs further clarification. The study includes only 15 PP cases and 44 comparison group participants, which may limit the representativeness of the results for the entire population of PP cases. Therefore, this study should be presented as a pilot study, due to the small sample size. I therefore suggest the following title : "Knowledge, Attitude and Practices among Healthcare Workers towards Pulmonary Plague Infection following an Outbreak in Madagascar, 2017 : A pilot study "

The demographic data are presented for PP cases and the comparison group, but not all results are compared between PP cases and the comparison group. The methodology requires further clarification to ensure the rigor and reproducibility of the study.

The percentages shown in the tables are often inconsistent, sometimes totaling less than or exceeding 100%. The authors note that the study shows that one year after the 2017 plague epidemic, HCWs in urban areas in Madagascar had a good level of knowledge. However, they do not specify the criteria used to determine a "good level of knowledge."

The authors should specify whether the data from this study are available, in a Data Availability section.

To improve the quality of the manuscript, we encourage the authors to incorporate the following suggestions.

ABSTRACT:

The abstract accurately reflects the objectives, findings, and provides a clear overview of the background, and key results. The results could be strengthened by emphasizing the comparison of plague knowledge between PP cases and the comparison group.

INTRODUCTION

The paper provides adequate background on plague, KAP (Knowledge, Attitudes, and Practices) surveys, and the 2017 outbreak in Madagascar.

Line 51: "Despite the good overall knowledge" � What are the criteria used to define "good overall knowledge"? This should be clarified in the methodology section.

Line 72: "Relatively high number of PP cases among HCWs reported during the 2017 Malagasy outbreak." Please specify the number or prevalence.

Line 86: "Only limited literature on experiences of HCWs on treatment of pulmonary plague in hospital." Please cite some examples if they exist.

MATERIALS AND METHODS

The methods are appropriate for the study’s objectives. The data collection and analysis techniques are generally well-described. However, I suggest adding a detailed explanation of the sample size calculation to enhance reproducibility.

Study design:

Line 93: "We conducted a cross-sectional survey in hospitals..." � How many hospitals were included in the study ?

Line 98: "Recruitment of study participants was conducted between 13 and 27 August 2018." � There was a one-year gap between the end of the 2017 epidemic and the surveys. This is therefore a retrospective study. Please clarify how recall bias was controlled during data collection.

Line 108: "Comparison HCWs were systematically sampled from staff lists to recruit 33% of each department’s HCWs." � Why was this 33% proportion chosen? Is it supported by literature review ? If so, please provide a reference.

Data collection:

Line 116: "The first three sections applied to all participants..." Further, in Line 120, "HCWs who had worked in the hospital or a mobile unit during the 2017 epidemic also completed the 4th section, which included questions on practices." � Please specify how many participants completed each section.

Lines 127-129: "The 5th section was only completed by HCWs who were notified as a PP case during the outbreak and contained questions about the disease, such as symptoms, onset of symptoms, and treatment." � However, questions about symptoms and treatment are addressed in Table 2 for all 59 participants. Does this imply that additional analyses were conducted but are not presented in this article?

RESULTS

The results are clearly presented but require a reorganization in how they are presented. The description of the tables should be provided in full, and the corresponding table should be inserted after the text. Currently, the authors partially describe the table, insert it, and then continue with the description. This approach disrupts the flow and should be revised to enhance clarity and readability.

Characteristics of the study population

Line 155: "These HCWs were working in seven different institutions..." � Please specify these institutions.

In Table 1, for the profession "MD"� Please write out the full term (e.g., "Medical Doctor").

Lines 172-173: "The distribution of professional groups among HCW PP cases and the HCW of the comparison group was comparable." � By "comparable," do you mean « similar »?

Line 178, Table 2: The study is presented as a comparative analysis between PP cases and the comparison group. � So, the authors should provide a comparative table between PP cases and the comparison group. If not, please specify in the methodology section, which analyses involve comparisons between PP cases and the comparison group and justify why comparisons are not made for all analyses.

Verify/Recalculate the proportions in Table 2. For example, "Some agreement" = 1 (1.7%) and "Total agreement" = 58 (98%), which totals 99.7% instead of 100%.

For the question, "To what extent do you agree with the following statement: 'Certain people are immune towards PP'," the total is 101.3% instead of 100%.

Tables 3 and 4: � The authors should provide a comparative table between PP cases and the comparison group. Also, verify/recalculate the proportions in these tables.

Table 5: Verify/recalculate the proportions in the table. Many proportions are either above or below 100%.

Lines 237-238: "After the epidemic, 21% attended training on health care provision for PP patients (Table 4)." � Elements of interpretation for Table 4 should be included before Table 4, not after Table 5.

DISCUSSION

Line 257: "We found basic PP knowledge to be good" �Specify in the methodology the criteria used to define good or poor knowledge in this study.

Reviewer #2:  This manuscript addresses an important and underexplored topic regarding the knowledge, attitudes, and practices of healthcare workers (HCWs) during a pulmonary plague outbreak in Madagascar. The study design is valuable and the inclusion of diverse HCW roles—from doctors to cleaning staff—adds depth. I appreciate that the authors addressed comments from a previous version.

However, there are still sections that would benefit from clearer articulation, particularly around the description of the study groups and case definitions. The paragraph explaining the comparison of PCR-confirmed cases versus other HCWs, for instance, is essential but currently difficult to follow. A diagram illustrating the sampling process and case categorization would greatly improve clarity. Additionally, some aspects of the questionnaire distribution across diverse HCW roles (e.g., clinical vs. non-clinical staff) could be justified further, especially if the same questions were applied across the board.

I also suggest expanding the interpretation of findings regarding access to chemoprophylaxis. For instance, HCW PP cases may have sought medication on their own due to fear or perceived urgency, not only due to systemic barriers. Highlighting such nuances would strengthen the discussion.

Overall, this study makes an important contribution, but some refinement in structure and clarity would help convey the message more effectively.

**********

-->6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .-->

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-25-02320_reviewer.pdf

PLoS One. 2025 Dec 5;20(12):e0336589. doi: 10.1371/journal.pone.0336589.r002

Author response to Decision Letter 1


14 Oct 2025

Dear reviewers,

I hope this message finds you well.

My co-author team and I have responded to your concerns in a "response to reviewers" letter as well as incorporating changes in the manuscript. Due to challenges in reaching out to the different co-authors, this took a bit of time, - I would like to apologize for the delay. Please do not hesitate to contact me anytime for further questions. Best regards, Thomas Paerisch

Attachment

Submitted filename: Response to reviewers.docx

pone.0336589.s004.docx (28.1KB, docx)

Decision Letter 1

Beza Ramasindrazana

29 Oct 2025

Knowledge, attitude and practices among Healthcare Workers towards Pulmonary Plague Infection following an outbreak in Madagascar, 2017: A pilot study

PONE-D-25-02320R1

Dear Dr. Thomas Paerisch,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Beza Ramasindrazana

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you very much for the responses you provided following reviewers' comments and suggestions. I think that your manuscript is now suitable for publication in PlosOne.

Acceptance letter

Beza Ramasindrazana

PONE-D-25-02320R1

PLOS ONE

Dear Dr. Paerisch,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Beza Ramasindrazana

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Questionnaire “Inclusivity in global research”.

    (DOCX)

    pone.0336589.s001.docx (66.2KB, docx)
    Attachment

    Submitted filename: PONE-D-25-02320_reviewer.pdf

    Attachment

    Submitted filename: Response to reviewers.docx

    pone.0336589.s004.docx (28.1KB, docx)

    Data Availability Statement

    Interested researchers can request the de-identified, anonymized dataset underlying the results presented in this study from raharina4@hotmail.com.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES